Advertisement

Topics

Neon Therapeutics Announces Pricing of Initial Public Offerings

12:11 EDT 27 Jun 2018 | Investing News Network

Neon Therapeutics (Nasdaq:NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced the pricing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $16.00 per share, before underwriting discounts and commissions. As quoted in the press release: In addition, Neon Therapeutics has granted the underwriters a 30-day option to … Continued

The post Neon Therapeutics Announces Pricing of Initial Public Offerings appeared first on Investing News Network.

Original Article: Neon Therapeutics Announces Pricing of Initial Public Offerings

NEXT ARTICLE

More From BioPortfolio on "Neon Therapeutics Announces Pricing of Initial Public Offerings"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...